166 related articles for article (PubMed ID: 6396971)
1. [Polyvinylpyridine N-oxide (Bay 3504, P-204, PVNO) in the treatment of human silicosis].
Prügger F; Mallner B; Schlipköter HW
Wien Klin Wochenschr; 1984 Dec; 96(23):848-53. PubMed ID: 6396971
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up observations of the therapeutic effect of PVNO on human silicosis.
Zhao JD; Liu JD; Li GZ
Zentralbl Bakteriol Mikrobiol Hyg B; 1983 Oct; 178(3):259-62. PubMed ID: 6659745
[TBL] [Abstract][Full Text] [Related]
3. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
Golodnikov IuN
Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
[No Abstract] [Full Text] [Related]
4. [Inhalation treatment of silicosis with Kexiping].
Gurilkov T; Stoevska M
Probl Khig; 1989; 14():161-6. PubMed ID: 2635309
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic effectiveness of polyvinoxide in silicosis and silicotuberculosis].
Zislin DM; Gol'del'man AG; Katsnel'son BA; Tikhotskaia LI; Rassokhina TG
Gig Tr Prof Zabol; 1985 Nov; (11):21-5. PubMed ID: 4085887
[No Abstract] [Full Text] [Related]
6. [Use of polyvinylpyridine N-oxide for treating experimental silicosis and anthracosilicosis].
Deĭnega VG; Bolonova LN; Sukhanov VV; Zemliakova LF; Tkachuk SV
Gig Tr Prof Zabol; 1977; (6):25-8. PubMed ID: 892540
[No Abstract] [Full Text] [Related]
7. [Effect of inhalations of polyvinylpyridine-N-oxide on the development of experimental silicosis].
Rodkina BS; Bolonova LN
Farmakol Toksikol; 1979; 42(1):81-4. PubMed ID: 421895
[TBL] [Abstract][Full Text] [Related]
8. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
Gel'fon IA
Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
[No Abstract] [Full Text] [Related]
9. The effects of tetrandrine (TT) and polyvinylpyridine-N-oxide (PVNO) on gene expression of type I and type III collagens during experimental silicosis.
Liu BC; He YX; Miao Q; Wang HH; You BR
Biomed Environ Sci; 1994 Sep; 7(3):199-204. PubMed ID: 7848548
[TBL] [Abstract][Full Text] [Related]
10. [Advances in the study of anti-silicotic agents].
Huang FZ; Li QL; Qu SJ
Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Apr; 9(2):118-21. PubMed ID: 3527609
[No Abstract] [Full Text] [Related]
11. [Studies on serum angiotensin-I-converting enzyme activity of experimental silicosis in rats].
Lin J
Zhonghua Yu Fang Yi Xue Za Zhi; 1990 Sep; 24(5):274-6. PubMed ID: 2175695
[TBL] [Abstract][Full Text] [Related]
12. Long-term test on rhesus monkeys for the PVNO therapy of anthracosilicosis.
Weller W
Inhaled Part; 1975 Sep; 4 Pt 1():379-87. PubMed ID: 829443
[TBL] [Abstract][Full Text] [Related]
13. A biochemical study on combined treatment of experimental silicosis with tetradrine-PVNO and tetradrine-QOHP in rats.
Yu L; Zhou CQ; Li YR; Qu L; Xing KJ; Du QC
Biomed Environ Sci; 1995 Sep; 8(3):265-8. PubMed ID: 8561927
[TBL] [Abstract][Full Text] [Related]
14. [Pathological findings after PVNO treatment of human anthracosilicosis].
Oellig WP; Böhm E; Schejbal V; Löbbecke F
Beitr Silikoseforsch Pneumokoniose; 1975; 27(2):63-76. PubMed ID: 1243872
[No Abstract] [Full Text] [Related]
15. [Results of a clinical trial of polyvinoxide in silicosis].
Glotova KV; Senkevich NA; Kaliteevskaia TN; Pichugin VA; Manzhosova GB
Gig Tr Prof Zabol; 1981 Aug; (8):14-7. PubMed ID: 7026373
[No Abstract] [Full Text] [Related]
16. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
Haas P; Huber W
Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
[No Abstract] [Full Text] [Related]
17. [Cytopharmacologic effect of using polyvinylpyridine-N-oxide in experimental silicosis].
Arutiunov VD; Kruglikov GG; Batsura IuD; Fedorova VI
Biull Eksp Biol Med; 1977 Mar; 83(3):371-4. PubMed ID: 856357
[TBL] [Abstract][Full Text] [Related]
18. [Trials of casual treatment of silicosis].
Idec-Sadkowska I; Andrzejak R; Antonowicz-Juchniewicz J; Kaczmarek-Wdowiak B
Med Pr; 2006; 57(3):271-80. PubMed ID: 17125034
[TBL] [Abstract][Full Text] [Related]
19. The prophylactic use of polyvinylpyridine-N-oxide (PVNO) in baboons exposed to quartz dust.
Goldstein B; Rendall RE
Environ Res; 1987 Apr; 42(2):469-81. PubMed ID: 3032603
[TBL] [Abstract][Full Text] [Related]
20. Poly (2-vinylpyridine 1-oxide) in silicosis therapy: effective molecular weight.
Hasirci VN; Holt PF
Int Arch Occup Environ Health; 1977; 38(3):177-88. PubMed ID: 832913
[No Abstract] [Full Text] [Related]
[Next] [New Search]
